Cargando…

Prevalence of chronic kidney disease after preeclampsia

BACKGROUND: Preeclampsia (PE), an endothelial disease that affects kidney function during pregnancy, is correlated to an increased future risk of cardiovascular and chronic kidney disease. The Kidney Disease Improving Global Outcomes (KDIGO) 2012 guideline emphasizes the combined role of glomerular...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopes van Balen, Veronica Agatha, Spaan, Julia Jeltje, Cornelis, Tom, Spaanderman, Marc Erich August
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5437128/
https://www.ncbi.nlm.nih.gov/pubmed/27491315
http://dx.doi.org/10.1007/s40620-016-0342-1
_version_ 1783237531229224960
author Lopes van Balen, Veronica Agatha
Spaan, Julia Jeltje
Cornelis, Tom
Spaanderman, Marc Erich August
author_facet Lopes van Balen, Veronica Agatha
Spaan, Julia Jeltje
Cornelis, Tom
Spaanderman, Marc Erich August
author_sort Lopes van Balen, Veronica Agatha
collection PubMed
description BACKGROUND: Preeclampsia (PE), an endothelial disease that affects kidney function during pregnancy, is correlated to an increased future risk of cardiovascular and chronic kidney disease. The Kidney Disease Improving Global Outcomes (KDIGO) 2012 guideline emphasizes the combined role of glomerular filtration rate (GFR) and albuminuria in determining the frequency of monitoring of kidney function. OBJECTIVES: In this study we evaluated the prevalence of CKD in women with a history of PE. We investigated how many seemingly healthy women required monitoring of kidney function according to the KDIGO guideline. METHODS: We included 775 primiparous women with a history of PE. They were at least 4 months postpartum, and had no pre-existing hypertension, diabetes or kidney disease. We estimated GFR by the CKD-Epidemiology equation and urinary albumin loss by albumin creatinine ratio in a 24-h urine collection. RESULTS: Most women, 669 (86.3 %), had a normal GFR and absent albuminuria. Based on the KDIGO guideline, 13.7 % would require at least yearly monitoring of kidney function. Only 1.4 % were classified to be at high risk for kidney function deterioration. CONCLUSION: Monitoring of kidney function seems relevant for about one in seven women with a history of PE, mainly due to albuminuria. Albuminuria should be evaluated postpartum to identify those women that need further monitoring of kidney function. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s40620-016-0342-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5437128
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-54371282017-06-06 Prevalence of chronic kidney disease after preeclampsia Lopes van Balen, Veronica Agatha Spaan, Julia Jeltje Cornelis, Tom Spaanderman, Marc Erich August J Nephrol Original Article BACKGROUND: Preeclampsia (PE), an endothelial disease that affects kidney function during pregnancy, is correlated to an increased future risk of cardiovascular and chronic kidney disease. The Kidney Disease Improving Global Outcomes (KDIGO) 2012 guideline emphasizes the combined role of glomerular filtration rate (GFR) and albuminuria in determining the frequency of monitoring of kidney function. OBJECTIVES: In this study we evaluated the prevalence of CKD in women with a history of PE. We investigated how many seemingly healthy women required monitoring of kidney function according to the KDIGO guideline. METHODS: We included 775 primiparous women with a history of PE. They were at least 4 months postpartum, and had no pre-existing hypertension, diabetes or kidney disease. We estimated GFR by the CKD-Epidemiology equation and urinary albumin loss by albumin creatinine ratio in a 24-h urine collection. RESULTS: Most women, 669 (86.3 %), had a normal GFR and absent albuminuria. Based on the KDIGO guideline, 13.7 % would require at least yearly monitoring of kidney function. Only 1.4 % were classified to be at high risk for kidney function deterioration. CONCLUSION: Monitoring of kidney function seems relevant for about one in seven women with a history of PE, mainly due to albuminuria. Albuminuria should be evaluated postpartum to identify those women that need further monitoring of kidney function. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s40620-016-0342-1) contains supplementary material, which is available to authorized users. Springer International Publishing 2016-08-05 2017 /pmc/articles/PMC5437128/ /pubmed/27491315 http://dx.doi.org/10.1007/s40620-016-0342-1 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Lopes van Balen, Veronica Agatha
Spaan, Julia Jeltje
Cornelis, Tom
Spaanderman, Marc Erich August
Prevalence of chronic kidney disease after preeclampsia
title Prevalence of chronic kidney disease after preeclampsia
title_full Prevalence of chronic kidney disease after preeclampsia
title_fullStr Prevalence of chronic kidney disease after preeclampsia
title_full_unstemmed Prevalence of chronic kidney disease after preeclampsia
title_short Prevalence of chronic kidney disease after preeclampsia
title_sort prevalence of chronic kidney disease after preeclampsia
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5437128/
https://www.ncbi.nlm.nih.gov/pubmed/27491315
http://dx.doi.org/10.1007/s40620-016-0342-1
work_keys_str_mv AT lopesvanbalenveronicaagatha prevalenceofchronickidneydiseaseafterpreeclampsia
AT spaanjuliajeltje prevalenceofchronickidneydiseaseafterpreeclampsia
AT cornelistom prevalenceofchronickidneydiseaseafterpreeclampsia
AT spaandermanmarcerichaugust prevalenceofchronickidneydiseaseafterpreeclampsia